← Resources · November 16, 2026
Science & Technology GS2GS3 4 min read

WHO Warns Antimicrobial Resistance Is Outpacing Countries' Action: Only 42 of 183 Have Fully Working National Plans

What happened
01

The World Health Organization (WHO) released findings from its 2026 survey of 183 countries on how they are fighting antimicrobial resistance (AMR), the problem of germs no longer dying when we use medicines against them.

02

173 of the 183 countries now have a national action plan on AMR, up from 79 in 2017. But only 42 countries (fewer than one in five) said their plan was financed, implemented and monitored.

03

Only 36% of countries have a national reference laboratory that can test for resistance in all the bacteria and fungi WHO tracks. The target for 2030 is 80%.

04

In 2023, one in six laboratory-confirmed bacterial infections reported to WHO did not respond to the usual antibiotics.

05

WHO said AMR directly caused more than 1 million deaths in 2021 and was linked to about 4.7 million more. It could cause about 39 million deaths between now and 2050.

06

WHO released two new tools to improve testing: one lists the tests needed at each level of health care, and the other compiles 73 laboratory procedures. It said progress must speed up to meet the 2030 targets.

Static topic 1 of 3 · Science & Technology

Antimicrobial Resistance (AMR): A Global Health Priority

Antimicrobial resistance (AMR) happens when bacteria, viruses, fungi or parasites change over time and stop responding to the medicines that used to kill them. When this happens, common infections become hard or impossible to treat. A simple urine infection or a small wound can then become dangerous. AMR is often called a "silent pandemic" because it kills millions of people slowly, without the sudden alarm of an outbreak like Covid-19.

Connection to this news

WHO's new survey shows that the world is not moving fast enough against AMR. One in six confirmed bacterial infections already resists treatment, and only 36% of countries have labs that can test for resistance in all priority germs. This is why WHO is pushing better testing and wiser antibiotic use.

Static topic 2 of 3 · Science & Technology

India's National Action Plan on Antimicrobial Resistance (NAP-AMR)

India's National Action Plan on Antimicrobial Resistance (NAP-AMR) is the country's main roadmap to slow down the spread of drug-resistant germs. It brings many ministries together, because AMR is caused by what happens in hospitals, farms, fish ponds, drug factories and rivers. India released its first plan in April 2017 for 2017 to 2021, and a second version, NAP-AMR 2.0, on 18 November 2025 for 2025 to 2029.

Connection to this news

WHO found that only 42 of 183 countries have AMR plans that are financed, implemented and monitored, far from the 2024 UN goal of 60% of countries with funded plans by 2030. India's NAP-AMR 2.0, with separate budgets for each ministry, is an attempt to move from a plan on paper to a plan that is funded and tracked.

Static topic 3 of 3 · Science & Technology

One Health Approach

One Health is a way of thinking about health that treats the health of humans, animals, plants and the environment as one connected system. It says that we cannot keep people healthy if animals are sick or nature is damaged. So doctors, vets, farm experts and environment experts must plan and act together, not separately.

Connection to this news

WHO says that infection prevention, vaccination, clean water and sanitation, and wise antibiotic use are the main levers against AMR. These cut across human, animal and environmental health, which is why countries' AMR plans are built on the One Health approach.

Key facts & data
  • WHO 2026 survey: 183 countries assessed
  • 173 countries have a national AMR action plan (79 in 2017)
  • Only 42 countries (fewer than 1 in 5) have plans that are financed, implemented and monitored
  • 36% of countries have a national reference lab able to test resistance in all WHO-monitored bacteria and fungi; 2030 target: 80%
  • 2023: one in six laboratory-confirmed bacterial infections reported to WHO was resistant to treatment
  • 2021: more than 1 million deaths directly caused by AMR; about 4.7 million more linked to it
  • Projection: about 39 million AMR deaths between now and 2050
  • New WHO tool compiles 73 laboratory procedures
  • 2024 UN target: at least 60% of countries with funded national action plans by 2030
  • India: NAP-AMR 2.0 (2025 to 2029) launched 18 November 2025
Read it? Now lock it in. The quiz for this day’s brief covers this story.
Take the quiz